Pembrolizumab Promising in Advanced Esophageal Cancer (CME/CE)

(MedPage Today) -- 30% of PD-L1-positive patients achieve partial response in small study

Source: MedPage Today Gastroenterology - January 7, 2018 Category: Gastroenterology Source Type: news